134 related articles for article (PubMed ID: 27065754)
1. SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line.
Zhang Y; Jiang F; Bao W; Zhang H; He X; Wang H; Wan X
Cancer Cell Int; 2016; 16():29. PubMed ID: 27065754
[TBL] [Abstract][Full Text] [Related]
2. SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer.
Zhou W; Wang K; Wang J; Qu J; Du G; Zhang Y
Onco Targets Ther; 2019; 12():8275-8286. PubMed ID: 31632077
[TBL] [Abstract][Full Text] [Related]
3. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
5. Wilms' Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer.
Xie W; Liu N; Wang X; Wei L; Xie W; Sheng X
Front Oncol; 2021; 11():598344. PubMed ID: 33680959
[TBL] [Abstract][Full Text] [Related]
6. Chronic BDE-47 Exposure Aggravates Malignant Phenotypes and Chemoresistance by Activating ERK Through ERα and GPR30 in Endometrial Carcinoma.
Zhang F; Peng L; Huang Y; Lin X; Zhou L; Chen J
Front Oncol; 2019; 9():1079. PubMed ID: 31737560
[TBL] [Abstract][Full Text] [Related]
7. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
8. Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer.
Wu J; Cheng Z; Xu X; Fu J; Wang K; Liu T; Wu C; Kong X; Yang Q; Yan G; Zhou H
Front Oncol; 2019; 9():422. PubMed ID: 31192127
[TBL] [Abstract][Full Text] [Related]
9. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
10. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells.
Li J; Sun H; Liu T; Kong J
Exp Ther Med; 2018 Nov; 16(5):4213-4224. PubMed ID: 30344696
[TBL] [Abstract][Full Text] [Related]
12. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
[TBL] [Abstract][Full Text] [Related]
13. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
14. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
15. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug.
Kalogera E; Roy D; Khurana A; Mondal S; Weaver AL; He X; Dowdy SC; Shridhar V
Gynecol Oncol; 2017 Jul; 146(1):187-195. PubMed ID: 28545688
[TBL] [Abstract][Full Text] [Related]
16. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
17. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
[TBL] [Abstract][Full Text] [Related]
18. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
19. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
Hu X; Wu N; Xia P; Yu S; Sun F; Chen J
Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403
[TBL] [Abstract][Full Text] [Related]
20. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
